Remove Chemotherapy Remove Communication Remove Events
article thumbnail

Enhancing collaboration to optimise medication therapy in older adults with cancer: a position paper from SOFOG-SFPO

Hospital Pharmacy Europe

4,5 Polypharmacy – daily use of five or more drugs – is common in these patients and increases the risk of DRPs, which can result in adverse outcomes such as postoperative complications, chemotherapy toxicities and functional decline. 10,11 This can be due to side effects of chemotherapy or the addition of certain supportive care medications.

article thumbnail

First-in-class MOv18 IgE antibody shows potential as safe and effective cancer therapy

Hospital Pharmacy Europe

Published in the journal Nature Communications , the researchers conducted a Phase I dose escalation trial , with the primary objective of exploring the safety and tolerability of the MOv18 IgE antibody. The most common events were localised cutaneous toxicities including urticaria, pruritus and rash, which appeared to be dose-related.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fennec’s hearing loss drug for cancer patients wins breakthrough FDA nod

Pharmaceutical Technology

The current standard of care for many cancers is cisplatin chemotherapy or platinum therapy. Additionally , loss of hearing at a young age is associated with impaired communication, cognitive impairment, poorer mental health and quality of life. The therapeutic landscape.

FDA 52
article thumbnail

MSD’s Keytruda use in adenocarcinoma could be limited based on biomarker

Pharmaceutical Technology

In 2021, as part of the same Keynote-811 trial, the US Food and Drug Administration (FDA) granted accelerated approval to Keytruda for treating locally advanced unresectable or metastatic HER2-positive gastric or GEJ adenocarcinoma, in combination with trastuzumab and chemotherapy containing fluoropyrimidin and platinum.

article thumbnail

Cymbalta generic availability, cost, and dosage

The Checkup by Singlecare

Chemotherapy-Induced Peripheral Neuropathy Studies have shown that duloxetine may help prevent or reduce nerve pain in people who have been treated with chemotherapy. Communicate any concerns or questions about the switch to your healthcare provider, as they can offer personalized advice based on your medical history and overall needs.

Dosage 52
article thumbnail

Methotrexate interactions to avoid

The Checkup by Singlecare

It is known as an antineoplastic (chemotherapy) agent, a disease-modifying antirheumatic drug ( DMARD ), and an immunosuppressant agent. Methotrexate has distinct mechanisms of action for its use as chemotherapy versus immunosuppression in autoimmune diseases.

article thumbnail

Solutions for Constipation Relief

The Thyroid Pharmacist

Tegaserod : This medication was approved for IBS-C in 2002, but removed from the market in 2007 due to an increased risk of cardiovascular events. 82] Many of them do so by helping the gut to communicate with the central nervous system, essentially retraining it to move more efficiently. I wish you well on your healing journey!